Our study demonstrates a strong association between ONECUT2 gene-body DNA methylation and aggressive prostate cancer features, validated using public Illumina Infinium methylation datasets as well as targeted bisulfite sequencing and qRT-PCR in our needle biopsy cohort. The gene discussed is ONECUT2; the disease is prostate cancer.